| Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose DS Møller, MI Holt, M Alber, M Tvilum, AA Khalil, MM Knap, L Hoffmann Radiotherapy and Oncology 121 (1), 32-38, 2016 | 97 | 2016 |
| Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients M Tvilum, AA Khalil, DS Møller, L Hoffmann, MM Knap Acta Oncologica 54 (9), 1430-1437, 2015 | 48 | 2015 |
| Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy DS Møller, CM Lutz, AA Khalil, M Alber, MI Holt, M Kandi, HH Schmidt, ... Radiotherapy and Oncology 168, 234-240, 2022 | 17 | 2022 |
| Polyether Ionophore antibiotics target drug-resistant clinical isolates, Persister cells, and biofilms M Wollesen, K Mikkelsen, MS Tvilum, M Vestergaard, M Wang, RL Meyer, ... Microbiology spectrum 11 (4), e00625-23, 2023 | 4 | 2023 |
| Different benefits of adaptive radiotherapy for different histologies of NSCLC M Tvilum, CM Lutz, MM Knap, L Hoffmann, AA Khalil, MI Holt, M Kandi, ... Acta Oncologica 62 (11), 1426-1432, 2023 | 1 | 2023 |
| Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC M Tvilum, MM Knap, L Hoffmann, AA Khalil, AL Appelt, A Haraldsen, ... Clinical and Translational Radiation Oncology 45, 100737, 2024 | | 2024 |
| PO-1305 Pattern of failure of LD-SCLC treated with chemoradiotherapy: dependence on disease stage. HH Schmidt, DS Moeller, L Hoffmann, CM Lutz, M Kandi, LS Mortensen, ... Radiotherapy and Oncology 182, S1046, 2023 | | 2023 |
| PO-1306 Response to induction chemotherapy on PET/CT predicts post-RT progression in patients with NSCLC M Tvilum, MM Knap, AA Khalil, L Hoffmann, CM Lutz, A Appelt, ... Radiotherapy and Oncology 182, S1046-S1047, 2023 | | 2023 |
| HYPOXIA-DEPENDENT PRODUCTION AND ACTIVITY OF THE PKS/NRPS HYBRID BE-43547 T Tørring, T Poulsen, MS Tvilum 4th International Conference on Natural Product Discovery and Development in …, 2023 | | 2023 |
| Prognostic Image Biomarkers in the Treatment of Patients with Locally Advanced NSCLC M Tvilum, CM Lutz, L Hoffmann, A Khalil, A Appelt, M Alber, C Grau, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e393, 2022 | | 2022 |
| EP05. 01-017 Exploring the Benefits of Adaptive Radiotherapy in NSCLC-patients M Tvilum, CM Lutz, A Khalil, M Alber, MI Holt, M Kandi, HH Schmidt, ... Journal of Thoracic Oncology 17 (9), S274, 2022 | | 2022 |
| PO-1262 Early response to chemotherapy as predictor of locoregional and distant failure in NSCLC M Tvilum, MM Knap, CM Lutz, L Hoffmann, AA Khalil, A Haraldsen, ... Radiotherapy and Oncology 170, S1065-S1066, 2022 | | 2022 |
| PD-0664 Risk factors of radiation pneumonitis in modern adaptive radiotherapy CM Lutz, DS Møller, A Appelt, M Alber, L Hoffmann, AA Khalil, MI Holt, ... Radiotherapy and Oncology 170, S597-S599, 2022 | | 2022 |
| SP-0354 Image-guided adaptive radiotherapy in the treatment of lung cancer patients M Tvilum, MM Knap, L Hoffmann, AA Khalil, CM Lutz, DS Møller Radiotherapy and Oncology 133, S177, 2019 | | 2019 |
